Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Lannett Company Inc. recalls Niacin Extended-release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Products
  • Niacin Extended-release Tablets
Where it was sold

Nationwide within the United States

Nationwide

Units affected
3984 bottles
About this recall
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.